- The global checkpoint inhibitors market should reach $29.3 billion by 2023 from $14.9 billion in 2018 at a compound annual growth rate (CAGR) of 14.4% for the period 2018 to 2023.
- The global lysosomal storage diseases market should reach $7.6 billion by 2023 from $5.1 billion in 2018 at a compound annual growth rate (CAGR) of 8.3% for the period 2018 to 2023.
Report Scope
The pharmaceutical sector is undergoing expansions driven by the unmet need in several disease areas. Launch of novel therapies, that included cell and gene therapy with an increase in access to medicines is also driving the growth of the pharmaceutical market. The approval of second CAR T-cell therapy tisagenlecleucel (Kymriah) in 2018 signifies the dramatic progress in the field. Pharmaceutical sector witnessed uncertainties due to the US presidential elections, and weak economic growth in 2017 which have now settled down leading to steady growth in the sector.
Pharmaceutical industry is continuing the pursuit of drug discovery, and development for meeting the worldwide unmet need in the area of oncology, and orphan diseases with an unprecedented rigor. Pharma sector ratifies this trend with a rich cancer pipeline, availability of clinical and real-world data and an increase in associated investments. Pharma industry would surge owing to mergers and acquisitions that bolster company’s portfolio, drive innovation, and unlocks synergies. The merger announcement of Bristol-Myers Squibb and Celgene would create a new biopharmaceutical leader with deep and broad pipeline to deliver high-value innovation medicines.
Table of Contents
Chapter 1 Foreword
Foreword
Chapter 2 Cognition and Memory Enhancement Drugs: Technologies and Global Markets (PHM184A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Summary and Highlights
Market Definition
Ethics and Cognition and Memory-enhancing Drugs
Treatments Available for Dementia
Cholinesterase Inhibitors
Memantine
Nondrug Treatments for Dementia
Availability of Dementia Treatments
Side Effects of Cognition and Memory-enhancing Drugs
Benefits and Side Effects of Consuming Cognition Drugs
Technology Trends
Recent Studies Highlighting Potential of Cognition Drugs in Chess
Market Breakdown by Application
Alzheimer’s Disease
Patents Overview
Patent Analysis
Patents Filed in Asia-Pacific
Chapter 3 Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets (PHM153B)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of the Study
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Cancer
Recent Advances in Technology
Invasive Power
Circulating Tumor Cells
Phenotypic Characteristics
CTC Clusters
CTC Detection
Circulating Tumor Cells - Potential Uses
Circulating Tumor Cell Market - A New Approach
Current Status of the Market
Patents Overview
Key Patents
Chapter 4 Global Viral Vector Manufacturing Markets and Technologies Through 2022 (PHM172A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analyst’s Credentials
Related Research Reports
Summary and Highlights
Market and Technology Background
Market Potential
WHO
Market Segmentation
Segmentation by Type
Overview
Chapter 5 Checkpoint Inhibitors: Global Markets (PHM185A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Immuno-Oncology
Costimulatory Immune Checkpoint Targets
Inhibitory Immune Checkpoint Targets
Immunometabolic Modulatory Targets
Unmet Medical Needs
New Biomarkers to Stratify Patients
Relapse/Refractory Patients
PD-1/PD-L1 Agents Introduction
Market Forecasts
Chapter 6 Lysosomal Disease Treatments: Technologies and Global Markets (PHM183A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Definition
Lysosomes
Lysosomal Storage Diseases
Most Common LSDs
Market Breakdown by Region
North America
Chapter 7 High-Throughput Screening: Technologies and Global Markets (PHM205A)
Introduction
Study Goals and Objectives
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Evolution of High-Throughput Screening
Miniaturization of Assays for High-Throughput Screening
Optimization of High-Throughput Screening
Conclusion
Artificial Intelligence and Automated Devices in HTS
Mass Spectrometry (MS)
Imaging Mass Spectrometry
MALDI Mass Spectrometry
Secondary Ion Mass Spectrometer
Mass Spectrometry Instruments
Patent Analysis
Chapter 8 Neuroprotective Agents: Therapeutic Applications and Global Markets (PHM188A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Neuroprotection
Why Are Neuroprotective Therapies Needed?
Neuroprotective Strategies
Market Breakdown by Therapeutic Indication
Neuroprotective Agents for Cerebrovascular Disease